We are live on
!
Find out more
Creative Planning Portfolio holdings
AUM
$147B
1-Year Est. Return
18.73%
This Fund
S&P 500
This Quarter
Est. Return
+7.05%
1 Year Est. Return
+18.73%
3 Year Est. Return
+48.71%
5 Year Est. Return
+44.71%
10 Year Est. Return
+145.34%
AUM
$131B
AUM Growth
+$13.8B
(+12%)
Cap. Flow
+$6.04B
Cap. Flow
% of AUM
4.61%
Top 10 Holdings %
Top 10 Hldgs %
44.72%
Holding
4,042
New
364
Increased
2,601
Reduced
814
Closed
133
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Total Bond Market
BND
|
+$740M |
| 2 |
State Street SPDR Portfolio Developed World ex-US ETF
SPDW
|
+$544M |
| 3 |
NVIDIA
NVDA
|
+$407M |
| 4 |
iShares Core S&P 500 ETF
IVV
|
+$325M |
| 5 |
State Street SPDR Portfolio S&P 400 Mid Cap ETF
SPMD
|
+$276M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$232M |
| 2 |
Vanguard Large-Cap ETF
VV
|
+$58.3M |
| 3 |
Vanguard Total Stock Market ETF
VTI
|
+$46.4M |
| 4 |
iShares Core US Aggregate Bond ETF
AGG
|
+$40M |
| 5 |
Vanguard Real Estate ETF
VNQ
|
+$37.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.26% |
| 2 | Financials | 3.77% |
| 3 | Consumer Discretionary | 2.12% |
| 4 | Communication Services | 1.89% |
| 5 | Healthcare | 1.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1376
Moderna
MRNA
$21.5B
| $2.45M | ﹤0.01% |
94,939
-12,654
| -12% | -$353K |
|
1377
JPMorgan Core Plus Bond ETF
JCPB
$13.8B
| $2.45M | ﹤0.01% |
51,565
-2,641
| -5% | -$124K |
|
1378
Invesco S&P MidCap Quality ETF
XMHQ
$5.43B
| $2.45M | ﹤0.01% |
23,346
+3,829
| +20% | +$394K |
|
1379
US Foods
USFD
$21.4B
| $2.45M | ﹤0.01% |
31,945
+8,532
| +36% | +$678K |
|
1380
AST SpaceMobile
ASTS
$16.8B
| $2.45M | ﹤0.01% |
49,851
+8,422
| +20% | +$406K |
|
1381
Celsius Holdings
CELH
$6.93B
| $2.44M | ﹤0.01% |
42,520
+2,131
| +5% | +$111K |
|
1382
Waters Corp
WAT
$36.8B
| $2.44M | ﹤0.01% |
8,142
-1,927
| -19% | -$581K |
|
1383
iShares International Equity Factor ETF
INTF
$3.54B
| $2.44M | ﹤0.01% |
67,952
-2,779
| -4% | -$97.3K |
|
1384
Brown-Forman Class B
BF.B
$12B
| $2.44M | ﹤0.01% |
90,094
+25,822
| +40% | +$748K |
|
1385
Advanced Drainage Systems
WMS
$10.9B
| $2.43M | ﹤0.01% |
17,553
+948
| +6% | +$124K |
|
1386
Granite Construction
GVA
$5.45B
| $2.43M | ﹤0.01% |
22,184
+4,839
| +28% | +$497K |
|
1387
Enpro
NPO
$7.05B
| $2.43M | ﹤0.01% |
10,732
+2,436
| +29% | +$526K |
|
1388
Invesco Actively Managed Exch-Traded Commodity Fd Tr Invesco Optimum Yield Diversified Commodity Strategy No K-1 ETF
PDBC
$5.81B
| $2.42M | ﹤0.01% |
180,427
-28,775
| -14% | -$382K |
|
1389
First Merchants
FRME
$2.72B
| $2.42M | ﹤0.01% |
64,214
+15,282
| +31% | +$610K |
|
1390
Seacoast Banking Corp of Florida
SBCF
$3.26B
| $2.42M | ﹤0.01% |
79,447
+70,510
| +789% | +$2.09M |
|
1391
iShares US Medical Devices ETF
IHI
$3.02B
| $2.41M | ﹤0.01% |
40,165
+131
| +0.3% | +$8.01K |
|
1392
Protagonist Therapeutics
PTGX
$8.75B
| $2.41M | ﹤0.01% |
36,214
+6,010
| +20% | +$342K |
|
1393
John B. Sanfilippo & Son
JBSS
$949M
| $2.41M | ﹤0.01% |
37,415
+5,267
| +16% | +$341K |
|
1394
CubeSmart
CUBE
$9.53B
| $2.4M | ﹤0.01% |
59,125
+23,912
| +68% | +$974K |
|
1395
Invesco BulletShares 2028 Corporate Bond ETF
BSCS
$3.54B
| $2.4M | ﹤0.01% |
116,744
+1,489
| +1% | +$30.6K |
|
1396
FlexShares Quality Dividend Defensive Index Fund
QDEF
$543M
| $2.4M | ﹤0.01% |
30,000
| – | – |
|
|
AL
1397
DELISTED
Air Lease Corp
AL
| $2.4M | ﹤0.01% |
37,691
+23,481
| +165% | +$1.4M |
|
1398
Werner Enterprises
WERN
$2.54B
| $2.4M | ﹤0.01% |
91,033
+14,607
| +19% | +$410K |
|
1399
Primerica
PRI
$9.81B
| $2.39M | ﹤0.01% |
8,626
+2,864
| +50% | +$769K |
|
1400
Monro
MNRO
$525M
| $2.39M | ﹤0.01% |
133,247
+3,051
| +2% | +$50.1K |
|
Similar funds
Creative Planning's Q3 2025 Portfolio in Review
As of Q3 2025, Creative Planning held 4,042 positions worth $131B, up 12% from $117B the previous quarter. Its ten largest holdings account for 45% of the portfolio.
Creative Planning deployed $6.04B of net new capital in Q3 2025, opening 364 new positions and adding to 2,601 existing holdings. Its largest new stake was Amrize Ltd: 170,878 shares worth $8.29M.
By sector, the portfolio is most concentrated in Technology at 8.3% of assets, up from 7% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Vanguard FTSE Developed Markets ETF, an estimated $232M trimmed.
- Creative Planning's largest Q3 2025 buy was Amrize Ltd: 170,878 shares worth $8.29M.
- Creative Planning added most to Vanguard Total Bond Market in Q3 2025, an estimated $740M increase.
- Creative Planning's biggest Q3 2025 reduction was Vanguard FTSE Developed Markets ETF, cutting an estimated $232M.
- Creative Planning fully exited Ansys in Q3 2025, selling an estimated $4.86M.
- Creative Planning's ten largest holdings make up 45% of its $131B portfolio in Q3 2025.
- Creative Planning opened 364 new positions and closed 133 in Q3 2025.
- Creative Planning's portfolio value rose 12% quarter-over-quarter to $131B.
Based on Creative Planning's 13F filing for Q3 2025, filed 14 Nov 2025.